author-photo

Sylvia Lee

University of Washington

18

Papers

457

Citations

Citation Trend

Filter By

Papers (18) Sort By

JournalConferenceOthers

Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of ECOG performance status on recurrent/metastatic head and neck squamous cell carcinomas treated with anti-PD1 inhibitors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I experience with first in class TnMUC1 targeted chimeric antigen receptor T-cells in patients with advanced TnMUC1 positive solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic value of early FDG PET response imaging and peripheral immunologic biomarkers: sub-study of a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer

2021 Advances in radiation oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT235: A Phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
P14.05 Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy.

2021 Cancer treatment and research
Show All
- Source
- Cite
- Save
Citations (0)
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.

2021 Journal of Palliative Medicine
Show All
- Source
- Cite
- Save
Citations (0)
End-of-life health care utilization (EOLHCU) in patients with recurrent, metastatic head and neck squamous cell carcinoma (RMHNSCC) treated with immune checkpoint inhibitors (IO).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic role of mid-treatment PET/CT and plasma cytokines in patients undergoing chemoradiation for locally advanced non-small cell lung cancer (LA-NSCLC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号